Breast Conservation Therapy for Patients With Locally Advanced Breast Cancer

Seminars in Radiation Oncology

Volumn 19, Issue 4, 2009, Pages 229-235

  Alm El Din, Mohamed A ^a,b   Taghian, Alphonse G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b TANTA UNIVERSITY HOSPITAL   (Egypt)

Author keywords

breast cancer; breast conservation; locally advanced

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; PREDNISONE; VINCRISTINE;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER INVASION; CANCER RECURRENCE; CANCER REGRESSION; DISEASE FREE SURVIVAL; HUMAN; LYMPH NODE IRRADIATION; LYMPH NODE METASTASIS; MINIMAL RESIDUAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PATIENT SELECTION; PREDICTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL RATE; TUMOR REGRESSION; TUMOR VOLUME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL;

EID: 69249221473     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2009.05.005     Document Type: Review

References (55)

1. Singletary S.E., McNeese M.D., and Hortobagyi G.N. Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma. Cancer 69 (1992) 2849-2852
2. Fisher B., Brown A., Mamounas E., et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15 (1997) 2483-2493
3. van der Hage J.A., van de Velde C.J., Julien J.P., et al. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 19 (2001) 4224-4237
4. Wolmark N., Wang J., Mamounas E., et al. Preoperative chemotherapy in patients with operable breast cancer: Nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 30 (2001) 96-102
5. Heys S.D., Hutcheon A.W., Sarkar T.K., et al. Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial. Clin Breast Cancer 3 suppl 2 (2002) S69-S74
6. Lebowitz P.F., Eng-Wong J., Swain S.M., et al. A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer. Clin Cancer Res 10 (2004) 6764-6769
7. Bear H.D., Anderson S., Smith R.E., et al. Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 24 (2006) 2019-2027
8. Clark J., Rosenman J., Cance W., et al. Extending the indications for breast-conserving treatment to patients with locally advanced breast cancer. Int J Radiat Oncol Biol Phys 42 (1998) 345-350
9. Hunt K.K., Singletary S.E., and Smith T.L. Conservation surgery and radiation: the M.D. Anderson experience. In: Bland K.I., and Copeland III E.M. (Eds). The Breast. (ed 2) (1998), Saunders, Philadelphia, PA 1179
10. McIntosh S.A., Ogston K.N., Payne S., et al. Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy. Am J Surg 185 (2003) 525-531
11. Shen J., Valero V., Buchholz T.A., et al. Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy. Ann Surg Oncol 11 (2004) 854-860
12. Chen A.M., Meric-Bernstam F., Hunt K.K., et al. Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol 22 (2004) 2303-2312
13. Asoglu O., Muslumanoglu M., Igci A., et al. Breast conserving surgery after primary chemotherapy in locally advanced breast cancer. Acta Chir Belg 105 (2005) 62-68
14. Mauriac L., MacGrogan G., Avril A., et al. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS). Ann Oncol 10 (1999) 47-52
15. Buchholz T.A., Lehman C.D., Harris J.R., et al. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: A National Cancer Institute conference. J Clin Oncol 26 (2008) 791-797
16. Mauriac L., Durand M., Avril A., et al. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre. Ann Oncol 2 (1991) 347-354
17. Schwartz G.F., Birchansky C.A., Komarnicky L.T., et al. Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer 73 (1994) 362-369
18. Schwartz G.F., Lange A.K., and Topham A.K. Breast conservation following induction chemotherapy for locally advanced carcinoma of the breast (stages IIB and III). A surgical perspective. Surg Oncol Clin N Am 4 (1995) 657-669
19. Powles T.J., Hickish T.F., Makris A., et al. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 13 (1995) 547-552
20. Makris A., Powles T.J., Ashley S.E., et al. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol 9 (1998) 1179-1184
21. Kuerer H.M., Newman L.A., Smith T.L., et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 17 (1999) 460-469
22. Veronesi U., Bonadonna G., Zurrida S., et al. Conservation surgery after primary chemotherapy in large carcinomas of the breast. Ann Surg 222 (1995) 612-618
23. Bonadonna G., Valagussa P., Brambilla C., et al. Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. J Clin Oncol 16 (1998) 93-100
24. Gardin G., Rosso R., Campora E., et al. Locally advanced non-metastatic breast cancer: analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approach. Eur J Cancer 31A (1995) 1428-1433
25. von Minckwitz G., Costa S.D., Eiermann W., et al. Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel. J Clin Oncol 17 (1999) 1999-2005
26. Clouth B., Chandrasekharan S., Inwang R., et al. The surgical management of patients who achieve a complete pathological response after primary chemotherapy for locally advanced breast cancer. Eur J Surg Oncol 33 (2007) 961-966
27. Rustogi A., Budrukkar A., Dinshaw K., et al. Management of locally advanced breast cancer: evolution and current practice. J Cancer Res Ther 1 (2005) 21-30
28. Mathew J., Asgeirsson K.S., Cheung K.L., et al. Neoadjuvant chemotherapy for locally advanced breast cancer: a review of the literature and future directions. Eur J Surg Oncol 35 (2009) 113-122
29. Harms S.E., Flamig D.P., Hesley K.L., et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 187 (1993) 493-501
30. Fischer U., Kopka L., and Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213 (1999) 881-888
31. Mumtaz H., Hall-Craggs M.A., and Davidson T. Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol 169 (1997) 417-424
32. Liberman L., Morris E.A., Dershaw D.D., et al. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol 180 (2003) 901-910
33. Schelfout K., Van Goethem M., Kersschot E., et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol 30 (2004) 501-507
34. Balu-Maestro C., Chapellier C., Bleuse A., et al. Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Res Treat 72 (2002) 145-152
35. Rosen E.L., Blackwell K.L., Baker J.A., et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 181 (2003) 1275-1282
36. Weatherall P.T., Evans G.F., Metzger G.J., et al. MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation. J Magn Reson Imaging 13 (2001) 868-875
37. Yeh E., Slanetz P., Kopans D.B., et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 184 (2005) 868-877
38. Partridge S.C., Gibbs J.E., Lu Y., et al. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 179 (2002) 1193-1199
39. Kim S.J., Kim S.K., Lee E.S., et al. Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy. Ann Oncol 15 (2004) 1352-1357
40. Edeiken B.S., Fornage B.D., Bedi D.G., et al. US-guided implantation of metallic markers for permanent localization of the tumor bed in patients with breast cancer who undergo preoperative chemotherapy. Radiology 213 (1999) 895-900
41. Oh J.L., Nguyen G., Whitman G.J., et al. Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer 110 (2007) 2420-2427
42. Buchholz T.A., Tucker S.L., Masullo L., et al. Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J Clin Oncol 20 (2002) 17-23
43. Huang E.H., Tucker S.L., Strom E.A., et al. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol 22 (2004) 4691-4699
44. McGuire S.E., Gonzalez-Angulo A.M., Huang E.H., et al. Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 68 (2007) 1004-1009
45. Garg A.K., Strom E.A., McNeese M.D., et al. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 59 (2004) 138-145
46. Mamounas T: Sentinel node biopsy after neoadjuvant chemotherapy: The pros. Presented at Preoperative Therapy in Invasive Breast Cancer: Reviewing the State of the Science and Exploring New Research Directions. National Cancer Institute, March 26, 2007, Bethesda, MD
47. Chen A.M., Meric-Bernstam F., Hunt K.K., et al. Breast conservation after neoadjuvant chemotherapy. Cancer 103 (2005) 689-695
48. Huang E.H., Strom E.A., Perkins G.H., et al. Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. Int J Radiat Oncol Biol Phys 66 (2006) 352-357
49. Thomas E., Holmes F.A., Smith T.L., et al. The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial. J Clin Oncol 22 (2004) 2294-2302
50. Rouzier R., Extra J.M., Klijanienko J., et al. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol 20 (2002) 1304-1310
51. Kuerer H.M., Newman L.A., Buzdar A.U., et al. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. Am J Surg 176 (1998) 502-509
52. Touboul E., Lefranc J.P., Blondon J., et al. Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3 cm or locally advanced non-inflammatory breast cancer. Radiother Oncol 42 (1997) 219-229
53. Mauri D., Pavlidis N., and Ioannidis J.P. Neoadjuvant versus adjuvant systemic treatment in breast cancer: A meta-analysis. J Natl Cancer Inst 97 (2005) 188-194
54. Mieog J.S., van der Hage J.A., and van de Velde C.J. Preoperative chemotherapy for women with operable breast cancer. Cochrane Database Syst Rev (2007) CD005002
55. Hortobagyi G.N., Ames F.C., Buzdar A.U., et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 62 (1988) 2507-2516